The deal aims to integrate the Contour Next-Gen and Contour Next One BGM systems into Avricore’s HealthTab PCOT platform. Both companies have the objective of supporting patients and pharmacists in Canada to better manage diabetes. The companies believe they can link daily blood glucose testing results and pattern history to a patient’s HealthTab account.
Additionally, the partnership seeks to support the utilization of each technology by enabling pharmacists and patients to take advantage of data insights.
Get the full story at our sister site, Drug Delivery Business News.